Pfizer psoriasis drug succeeds in late-stage trial

class="mandelbrot_refrag">Pfizer Inc said its experimental psoriasis drug was effective in treating the condition in a late-stage trial.

_0">

Two doses of the drug, tofacitinib, maintained the treatment effect in patients suffering from moderate-to-severe chronic plaque psoriasis, the company said.

The trial data showed that patients who stayed on the drug maintained the treatment effect and, among those who stopped therapy, some patients were able to regain the original treatment effect when given tofacitinib, Pfizer said.

(Reporting by Esha Dey in Bangalore; Editing by Savio D'Souza)

Popular posts from this blog

Oscar Pistorius photographed training by high school students

Interest rate cap on credit union is raised

Precious moments together...